Neogen EBIT Margin 2010-2025 | NEOG
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Neogen (NEOG) over the last 10 years. The current EBIT profit margin for Neogen as of February 28, 2025 is .
| Neogen EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-02-28 | $0.91B | $-0.44B | -48.23% |
| 2024-11-30 | $0.91B | $-0.43B | -47.05% |
| 2024-08-31 | $0.91B | $0.04B | 4.49% |
| 2024-05-31 | $0.93B | $0.06B | 6.27% |
| 2024-02-29 | $0.93B | $0.07B | 7.31% |
| 2023-11-30 | $0.92B | $0.07B | 7.83% |
| 2023-08-31 | $0.92B | $0.05B | 5.44% |
| 2023-05-31 | $0.82B | $0.04B | 4.50% |
| 2023-02-28 | $0.72B | $0.03B | 4.44% |
| 2022-11-30 | $0.63B | $0.02B | 3.49% |
| 2022-08-31 | $0.53B | $0.04B | 7.91% |
| 2022-05-31 | $0.53B | $0.06B | 11.01% |
| 2022-02-28 | $0.51B | $0.06B | 11.67% |
| 2021-11-30 | $0.50B | $0.07B | 13.92% |
| 2021-08-31 | $0.49B | $0.08B | 15.81% |
| 2021-05-31 | $0.47B | $0.07B | 15.81% |
| 2021-02-28 | $0.45B | $0.07B | 16.44% |
| 2020-11-30 | $0.43B | $0.07B | 16.40% |
| 2020-08-31 | $0.43B | $0.07B | 16.43% |
| 2020-05-31 | $0.42B | $0.07B | 16.03% |
| 2020-02-29 | $0.42B | $0.07B | 15.75% |
| 2019-11-30 | $0.42B | $0.07B | 16.31% |
| 2019-08-31 | $0.42B | $0.07B | 16.35% |
| 2019-05-31 | $0.42B | $0.07B | 16.39% |
| 2019-02-28 | $0.41B | $0.07B | 16.71% |
| 2018-11-30 | $0.41B | $0.07B | 17.07% |
| 2018-08-31 | $0.40B | $0.07B | 17.33% |
| 2018-05-31 | $0.40B | $0.07B | 17.59% |
| 2018-02-28 | $0.39B | $0.07B | 17.88% |
| 2017-11-30 | $0.38B | $0.07B | 17.68% |
| 2017-08-31 | $0.37B | $0.07B | 17.89% |
| 2017-05-31 | $0.36B | $0.07B | 18.11% |
| 2017-02-28 | $0.35B | $0.06B | 17.56% |
| 2016-11-30 | $0.34B | $0.06B | 17.25% |
| 2016-08-31 | $0.33B | $0.06B | 17.22% |
| 2016-05-31 | $0.32B | $0.06B | 17.70% |
| 2016-02-29 | $0.31B | $0.06B | 18.01% |
| 2015-11-30 | $0.30B | $0.06B | 18.87% |
| 2015-08-31 | $0.29B | $0.06B | 18.97% |
| 2015-05-31 | $0.28B | $0.05B | 18.73% |
| 2015-02-28 | $0.27B | $0.05B | 18.08% |
| 2014-11-30 | $0.27B | $0.05B | 17.74% |
| 2014-08-31 | $0.26B | $0.04B | 17.12% |
| 2014-05-31 | $0.25B | $0.04B | 17.34% |
| 2014-02-28 | $0.24B | $0.04B | 17.72% |
| 2013-11-30 | $0.23B | $0.04B | 18.58% |
| 2013-08-31 | $0.22B | $0.04B | 19.35% |
| 2013-05-31 | $0.21B | $0.04B | 19.23% |
| 2013-02-28 | $0.20B | $0.04B | 19.40% |
| 2012-11-30 | $0.20B | $0.04B | 18.97% |
| 2012-08-31 | $0.19B | $0.04B | 18.52% |
| 2012-05-31 | $0.19B | $0.03B | 18.38% |
| 2012-02-29 | $0.18B | $0.03B | 18.89% |
| 2011-11-30 | $0.18B | $0.03B | 19.21% |
| 2011-08-31 | $0.18B | $0.04B | 20.45% |
| 2011-05-31 | $0.17B | $0.04B | 21.39% |
| 2011-02-28 | $0.17B | $0.04B | 20.83% |
| 2010-11-30 | $0.16B | $0.03B | 20.63% |
| 2010-08-31 | $0.15B | $0.03B | 19.87% |
| 2010-05-31 | $0.14B | $0.03B | 19.29% |
| 2010-02-28 | $0.13B | $0.03B | 18.94% |
| 2009-11-30 | $0.13B | $0.02B | 18.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.092B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.329B | 27.30 |
| Boston Scientific (BSX) | United States | $151.960B | 38.05 |
| Stryker (SYK) | United States | $141.576B | 30.43 |
| EssilorLuxottica (ESLOY) | France | $131.433B | 0.00 |
| Medtronic (MDT) | Ireland | $108.503B | 15.84 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.360B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.382B | 26.36 |
| ResMed (RMD) | United States | $34.859B | 26.18 |
| GE HealthCare Technologies (GEHC) | United States | $31.175B | 15.16 |
| Agilent Technologies (A) | United States | $30.637B | 20.24 |
| Terumo (TRUMY) | Japan | $28.678B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.336B | 12.85 |
| Insulet (PODD) | United States | $17.646B | 75.46 |
| Baxter (BAX) | United States | $15.890B | 11.43 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.790B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.119B | 17.50 |
| Bio-Rad Laboratories (BIO) | United States | $6.788B | 23.50 |
| Prestige Consumer Healthcare (PBH) | United States | $4.059B | 19.37 |
| Perrigo (PRGO) | Ireland | $3.496B | 10.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 28.78 |
| Haemonetics (HAE) | United States | $3.214B | 15.12 |
| Envista Holdings (NVST) | United States | $2.745B | 22.19 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 15.23 |
| LeMaitre Vascular (LMAT) | United States | $2.092B | 47.73 |
| QuidelOrtho (QDEL) | United States | $1.928B | 16.15 |
| AtriCure (ATRC) | United States | $1.715B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.258B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.250B | 19.63 |
| BioLife Solutions (BLFS) | United States | $1.174B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.129B | 10.87 |
| InMode (INMD) | Israel | $1.003B | 9.18 |
| Phibro Animal Health (PAHC) | United States | $0.765B | 11.73 |
| Evolus (EOLS) | United States | $0.746B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.596B | 0.00 |
| CeriBell (CBLL) | United States | $0.587B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.574B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.61 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.493B | 0.00 |
| Surmodics (SRDX) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.419B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.346B | 15.02 |
| Verano Holdings (VRNOF) | United States | $0.307B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 24.82 |
| ZimVie (ZIMV) | United States | $0.264B | 15.78 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.237B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 4.43 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.89 |
| Brainsway (BWAY) | Israel | $0.168B | 52.29 |
| Organigram Global (OGI) | Canada | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.99 |
| Jin Medical (ZJYL) | China | $0.140B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.121B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.86 |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 0.00 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.11 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |